Skip to main content
SpringerLink
Log in

Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

The effects of the macrolide antimicrobial agents azithromycin, clarithromycin, erythromycin and roxithromycin on the prooxidative activity of stimulated human neutrophils have been investigated in vitro. Superoxide generation by activated neutrophils was measured by lucigenin-enhanced chemiluminescence. At the concentrations used (2.5–80 μg/ml) none of the test agents was cytotoxic, nor did they possess superoxide-scavenging properties. Treatment of neutrophils with all 4 macrolides was accompanied by dose-related inhibition of superoxide production by cells activated with FMLP or the calcium ionophore (A23187), while the responses activated by phorbol myristate acetate (PMA) or opsonized zymosan were minimally affected. The anti-oxidative interactions of roxithromycin with FMLP-activated neutrophils were neutralized by pretreatment of the cells with low, non-cytotoxic concentrations (0.5 μg/ml) of the prooxidative, proinflammatory bioactive phospholipids, lysophosphatidylcholine (LPC), platelet-activating factor (PAF) and lyso-PAF (LPAF). Using an assay of membrane-stabilizing activity, the macrolides antagonized the membrane-disruptive effects of LPC, PAF and LPAF, without affecting enzymes involved in their synthesis. These membrane-stabilizing interactions of macrolides with neutrophils may counteract the proinflammatory, prooxidative activity of several bioactive lipids which have been implicated in the pathogenesis of bronchial asthma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Itkin, I. H., andM. L. Menzel. 1970. The use of macrolide antibiotic substances in the treatment of asthma.J. Allergy 45:146–162.

    PubMed  Google Scholar 

  2. Spector, S. L., F. H. Katz, andR. S. Farr. 1974. Troleandomycin: effectiveness in steroiddependent asthma and bronchitis.J. Allergy Clin. Immunol. 54:367–379.

    Google Scholar 

  3. Suez, D., andS. J. Szefler. 1986. Excessive accumulation of mucus in children with asthma: a potential role for erythromycin? A case discussion.J. Allergy Clin. Immunol. 77:330–334.

    PubMed  Google Scholar 

  4. Mihatake, H., K. Suzuki, F. Taki, K. Takagi, andT. Satake. 1991. Effect of erythromycin on bronchial hyperresponsiveness in patients with bronchial asthma.Arzneim. Forsch. Drug Res. 41:552–556.

    Google Scholar 

  5. Rosenberg, S. M., H. Gerhand, M. M. Grunstein, andC. M. Schramm. 1991. Use of TAO with or without methylprednisolone in the treatment of severe asthma.Chest 100:849–850.

    PubMed  Google Scholar 

  6. Shimizu, T., M. Kato, H. Mochizuki, K. Tokuyama, K. Morikawa, andT. Kuroume. 1994. Roxithromycin reduces the degree of bronchial hyperresponsiveness in children with asthma.Chest 166:458–461.

    Google Scholar 

  7. Goswami, S. K., S. Kivity, andZ. Marom. 1990. Erythromycin inhibits respiratory glycoconjugate secretion from human airways in vitro.Am. Rev. Resp. Dis. 141:72–78.

    PubMed  Google Scholar 

  8. Tamaoki, J., K. Isono, N. Sakai, T. Kanemura, andK. Konno. 1992. Erythromycin inhibits C1 secretion across canine tracheal epithelial cells.Eur. Respir. J. 5:234–238.

    PubMed  Google Scholar 

  9. Takeyama, K., J. Tamaoki, A. Chiyotani, E. Tagaya, andK. Konno. 1993. Effect of macrolide antibiotics on ciliary motility in rabbit airway epithlium in vitro.J. Pharm. Pharmacol. 45:756–758.

    PubMed  Google Scholar 

  10. Miyachi, Y., A. Yoshioka, S. Imamura, andY. Niwa. 1986. Effect of antibiotics on the generation of reactive oxygen species.J. Invest. Dermatol. 86:449–453.

    PubMed  Google Scholar 

  11. Anderson, R. 1989. Erythromycin and roxithromycin potentiate human neutrophil locomotion by inhibition of leukoattractant-activated superoxide generation and autooxidation.J. Infec. Dis. 159:966–973.

    Google Scholar 

  12. Hirata, T., T. Izumi, andS. Oshima. 1989. Inhibitory effect of erythromycin on the production of oxygen radical and chemotactic factor for neutrophils.Am. Rev. Resp. Dis. 139:A484.

    Google Scholar 

  13. Labro, M. T., J. El Benna, andC. Babin-Chevaye. 1989. Comparison of the in vitro effect of several macrolides on the oxidative burst of human neutrophils.J. Antimicrob. Chemother. 24:561–572.

    PubMed  Google Scholar 

  14. Hand, W. L., D. L. Hand, andN. L. King-Thomson. 1990. Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes.Antimicrob. Agents Chemother. 34:863–870.

    PubMed  Google Scholar 

  15. Umeki, S. 1993. Anti-inflammatory action of erythromycin: its inhibitory effect on neutrophil NADPH-oxidase activity.Chest 104:1191–1193.

    PubMed  Google Scholar 

  16. Konno, S., M. Adachi, K. Asano, K. Okamoto, andT. Takahashi. 1993. Anti-allergic activity of roxithromycin: inhibition of interleukin-5 production from mouse T lymphocytes.Life Sci. 52:PL25–30.

    PubMed  Google Scholar 

  17. Peters, D. H., H. A. Friedel, andD. McTavish. 1993. Azithromycin: a review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy.Drugs 44:750–799.

    Google Scholar 

  18. Minkenberg, I., andE. Ferber. 1984. Lucigenin-dependent chemiluminescence as a new assay for NADPH-oxidase activity in particulate fractions of human polymorphonuclear leukocytes.J. Immunol. Meth. 71:61–67.

    Google Scholar 

  19. Anderson, R., A. D. Beyers, J. E. Savage, andA. E. Nel. 1988. Apparent involvement of phospholipase A2, but not protein kinase C, in the pro-oxidative interactions of clofazimine with human phagocytes.Biochem. Pharmacol. 37:4635–4641.

    PubMed  Google Scholar 

  20. Holmsen, H. E., E. Storm, andH. J. Day. 1972. Determinations of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma.Analyt. Biochem. 46:481–502.

    Google Scholar 

  21. Neu, H. C. 1991. The development of macrolides: clarithromycin in perspective.J. Antimicrob. Chemother. 27(Suppl A): 1–9.

    Google Scholar 

  22. Puri, S. K., andH. B. Lassman. 1987. Roxithromycin: a pharmacokinetic review of a macrolide.J. Antimicrob. Chemother. 20(Suppl B):89–100.

    PubMed  Google Scholar 

  23. Anderson, R., C. E. J. Van Rensburg, G. Joone, andP. T. Lukey. 1987. An in vitro comparison of the intraphagocytic bioactivity of erythromycin and roxithromycin.J. Antimicrob. Chemother. 20(Suppl B): 57–68.

    Google Scholar 

  24. Anderson, R., G. Joone, andC. E. J. Van Rensburg. 1988. An in vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent.J. Antimicrob. Chemother. 22:923–933.

    PubMed  Google Scholar 

  25. Gladue, R. P., G. M. Bright, R. E. Isaacson, andM. F. Newborg. 1989. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.Antimicrob. Agents Chemother. 33:277–282.

    PubMed  Google Scholar 

  26. Ishiguro, M., H. Koga, S. Kohno, T. Hayashi, K. Yamaguchi, andM. Hirota. 1989. Penetration of macrolides into human polymorphonuclear leukocytes.J. Antimicrob. Chemother. 24:719–729.

    PubMed  Google Scholar 

  27. Rubinek, T., andR. Levy. 1993. Arachidonic acid increases the activity of the assembled NADPH-oxidase in cytoplasmic membranes and endosomes.Biochim. Biophys. Acta. 1176:51–58.

    PubMed  Google Scholar 

  28. Dana, R., H. L. Malech, andR. Levy. 1994. The requirement for phospholipase A2 for activation of the assembled NADPH-oxidase in human neutrophils.Biochem. J. 297:217–223.

    PubMed  Google Scholar 

  29. Kusner, D. J., J. N. Aucott, D. Franceschi, M. M. Sarasua, S. J. Spagnuolo, andC. H. King. 1991. Protease priming of neutrophil superoxide production: effects on membrane lipid order and lateral mobility.J. Biol. Chem. 266:16465–16471.

    PubMed  Google Scholar 

  30. Wiles, M. E., J. A. Dykens, andC. D. Wright. 1994. Regulation of polymorphonuclear leukocyte membrane fluidity: effect of cytoskeletal modification.J. Leuk. Biol. 56:192–199.

    Google Scholar 

  31. Zimmerman, G. A., S. M.Prescott, and T. M.McIntyre. Platelet-activating factor: a fluid phase and cell-associated mediator of inflammation;In Inflammation: Basic Principles and Clinical Correlates. Gallin JI, Goldstein IM, Snyderman R, eds. New York; Raven Press Ltd. 149–176.

  32. Oishi, K., R. L. Raynor, P. A. Charp, andJ. F. Kuo. 1988. Regulation of protein kinase C by lysophospholipids.J. Biol. Chem. 263:6865–6871.

    PubMed  Google Scholar 

  33. Savage, J. E., A. J. Theron, andR. Anderson. 1993. Activation of neutrophil membrane-associated oxidative metabolism by ultraviolet radiation.J. Invest. Dermatol. 101:532–536.

    PubMed  Google Scholar 

  34. Engelberger, W., D. Bitter-Suermann, andU. Hadding. 1987. Influence of lysophospholipids and PAF on the oxidative burst.Internat. J. Immunopharmacol. 9:275–282.

    Google Scholar 

  35. Ginsburg, I., P. A. Ward, andJ. Varani. 1989. Lysophosphatides enhance superoxide responses of stimulated human neutrophils.Inflammation. 13:163–174.

    PubMed  Google Scholar 

  36. Perry, D. K., W. L. Hand, D. E. Edmondsen, andJ. D. Lambeth, 1992. Role of phospholipase D-derived diradylglycerol in the activation of the human neutrophil respiratory burst oxidase-inhibition by phosphatidic acid phosphohydrolase inhibitors.J. Immunol. 149:2749–2758.

    PubMed  Google Scholar 

  37. Aoshiba, K., A. Nayai, andK. Konno. 1995. Erythromycin shortens neutrophil survival by accelerating apoptosis.Antimicrob. Agents Chemother. 39:872–877.

    PubMed  Google Scholar 

  38. Barnes, P. J. 1989. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma.J. Allergy Clin. Immunol. 83:1013–1026.

    PubMed  Google Scholar 

  39. Mehta, D., S. Gupta, S. N. Gaur, S. V. Gangal, andK. P. Agrawal. 1990. Increased leukocyte phospholipase A2 activity and plasma lysophosphatidylcholine levels in asthma and rhinitis and their relationship to airway sensitivity to histamine.Am. Rev. Resp. Dis. 142:157–161.

    PubMed  Google Scholar 

  40. Marquardt, D. L., andL. L. Walker. 1991. Lysophosphatidycholine induces mast cell secretion and protein kinase C activition.J. Allergy. Clin. Immunol. 88:721–730.

    PubMed  Google Scholar 

  41. Ganbo, T., K. Hisamatsu, T. Nakazawa, A. Kanjo, andY. Murakami. 1991. Platelet activating factor (PAF) effects on ciliary activity of human paranasal sinus mucosa in vitro.Rhinology. 29:231–237.

    PubMed  Google Scholar 

  42. Nieminen, M. M., E. K. Moilanen, J-E. J. Nyholm, M. O. Koskinen, J. I. Karvonen, T. J. Metsä-Ketelä, andH. Vapaatalo. 1991. Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene B4 in man.Eur. Respir. J. 4:551–560.

    PubMed  Google Scholar 

  43. Feldman, C., R. Anderson, A. Theron, P. J. Cole, andR. Wilson. 1995. The effects of platelet activating factor (PAF) and lysophosphatidylcholine (LPC) on human ciliated epithelium in vitro.Am. J. Resp. Crit. Care Med. 151:A65.

    Google Scholar 

  44. Hovi, T., K. Josefesson, andO. V. Renkonen. 1983. Erythromycin absorption in healthy volunteers from single and multiple doses of enteric-coated pellets and tablets.Eur. J. Clin. Pharmacol. 25:719–729.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Research Council Unit for Inflammation and Immunity, Department of Immunology, Institute for Pathology, University of Pretoria, South Africa

    Ronald Anderson & Annette J. Theron

  2. Department of Medicine, University of the Witwatersrand, Johannesburg, South Africa

    Charles Feldman

Authors
  1. Ronald Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annette J. Theron
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Charles Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, R., Theron, A.J. & Feldman, C. Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils. Inflammation 20, 693–705 (1996). https://doi.org/10.1007/BF01488805

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01488805

Keywords

Search

Navigation